chrisvoncsefalvay/vaers-outcomes huggingface dataset:
3 years ago first dose; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a 60-year-old patient who received HBV (Engerix B) for prophylaxis.   Previously administered products included Engerix B (1st dose received 3 years ago of reporting date).   On an unknown date, the patient received the 2nd dose of Engerix B. On an unknown date, unknown after receiving Engerix B, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The health care professional from a doctor´s office called to report that the patient received 3 years ago Engerix-B first dose and did not completed rest doses, which led to incomplete course of vaccination. The reporter was in a rush ate the moment of the call so she requested a Follow-Up by postal. The reporter consented to follow up.
Fever-104 last night. shot given on 09/30/09. Patient took ADVIL.
patient recieved vaccines as listed, then 2 hours later, had a seizure at school that consisted of staring into space, no tonic-clonic activity.  Does have an underlying seizure disorder, but hadn't had seizures in 2 years.  Was given rectal diastat- transported to ER for somnolence and monitoring.  Had valproic acid level checked - level 53 (normal 50-100) and had increased dose.  Discharged around 4 hours later stable and fully recovered 10/9/09 Received medical records from date 9/23/09 DC DX: Seizure.  Presenting symptoms: Parent stated pt was at school after receiving 4 vaccines in the morning had a staring episode where she was unresponsive. Parent states no seizures in 2 years. Pt c/o feeling tired in ER. Exam WNL.
Within days after vaccination developed nasal and chest congestion, runny nose.  10/2 or 10/3  he went to an urgent care and started on azithromycin.  10/6 he went to his PCP with nosebleed, blood in his stool, oral lesions, and a body wide petechial rash.  He was prescribed an Albuterol inhaler, dexamethasone 40mg PO QD, Montelukast 10mg QD,  and BMX solution swish and spit for sore throat.  10/7 labs came back with platelets < 2 and an A1c of 6.7.  10/8 he was seen in clinic reporting no new symptoms.  Repeat CBC showed persistent platelets < 2.  He was directed to the ED and admitted 10/8 - 10/9.  He had 2 doses IVIG. He discharged on the decadron previously prescribed.
Administered vaccine from vial that's BUD was 6-26-21 at 10:15 A.M.  Vial was kept in refrigerator entire time prior to administration.
Chills, muscle & skeletal aches, headache, fever, nausea, jaw pain, tired. Slept for 36 hours.
01/02/22 History of Present Illness: The patient presents with SOB x1 day ago with associated myalgia, vomiting, HA, cough, right ankle pain, and weakness. Hx of HTN and rheumatoid arthritis. Pt is currently COVID-19 positive and reports to the ED due to acutely worsening symptoms. She also had a fall in the bathroom due to her weakness, causing her ankle pain. Pt is vaccinated for COVID-19 and was exposed to COVID-19 on 12/30/21.  The onset was 1  days ago.   Associated symptoms: cough, nausea, vomiting, myalgia, headache, weakness.
pt recvd vax; to er; was unresponsive & hypothermic; resucitation unsuccessful;
Body itch; internal mouth itch; This is a spontaneous report from a contactable other hcp (patient). A 58-years-old non-pregnant female patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Right in Jan2021 at the age of 58 years old (Batch/Lot Number: EL9262) as SINGLE DOSE for covid-19 immunisation. Medical history included asthma , breast cancer, Allergy to all seafood including shellfish and codeine. Prior to and since the vaccination the patient has not been diagnosed with COVID-19. Concomitant medications included exemestane (EXEMESTANE), omeprazole magnesium (PRILOSEC), cetirizine hydrochloride (ZYRTEC). On The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 29Jan2021 18:00 the patient experienced body itch and internal mouth itch, the patient took Benadryl and Tagamet as treatment for the events. Outcome of the events was recovered on an unspecified date 2021.   Follow-up (29Mar2021): No new information.
Pt had fever daily 101-6 x 6 days after shots. No other symptoms, she acted fussy on and off. It was reported to us today 12/15/06  Tylenol taken. Sym did leave after 6 days.
Shortness of breath/inability to take a complete breath. Started 1 day after vaccine-present
glaucoma; sharp pains to his right middle and index fingers; sharp pains to feet and toes of both feet; sharp pains to feet and toes of both feet; far sight is blurry; slight numbness to the right side of his face; dull pain in his stomach; This is a spontaneous report from a contactable consumer. This male consumer (patient) reported that: A male patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Right on Aug2021 as DOSE 2, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered on unspecified date as DOSE 1, SINGLE for covid-19 immunization. On an unspecified date, the patient experienced glaucoma, sharp pains to his right middle and index fingers, sharp pains to feet and toes of both feet, sharp pains to feet and toes of both feet, far sight is blurry, slight numbness to the right side of his face, dull pain in his stomach. Consumer called about the Pfizer COVID-19 vaccine who said it has been a week since he got his second injection and he is still experiencing side effects. He said that he has a dull pain in his stomach also that feels like he got punched in the stomach that hasn't gone away and has slight numbness to the right side of his face, which he had the shot in his right side arm. He do not know if it has to do with his glaucoma or not, but before all the shots his vision was good, now looking further his far sight is blurry. He said he called the eye doctor and has an appointment to check that out and seemed like everyone he knows was done with all side effects in one to two days, so he was concerned that he still has the feeling like he was punched in the stomach. Caller declined to complete a report, and says he just needed to know if this could be life threatening or if he just needed to see his doctor. No further details provided about other people who had side effects. Event glaucoma was considered as serious (medically significant). The clinical outcome of events were unknown.  Information on the Lot/batch number has been requested.
febrile sz;fever 30min p/vax;10hr later T104.7 R @ ER;+turned limp & had jerking motion of extremities;rushed to ER;
Hives am of 7/17/04: hives generalized. Consult with pediatrician. Treated with Benadryl qid
Information has been received from a physician concerning a female with anxiety who on an unspecified date was vaccinated intramuscularly with a third dose of Gardasil from a single dose vial (lot # not reported). The physician reported that after receiving the third dose of Gardasil, "almost immediately", the patient experienced dizziness. The patient sought unspecified medical attention. It was reported that "the patient is fine." Additional information has been requested.
Covid19 breakthrough.  1st vaccine received on 01/15/2021.  75 y/o with PMHX of metastic breast cancer s/p Right mastectomy, Keytruda, radiation, hypothyroid, malignant pleural effusions with bilat pleuryx cath placement presents to Medical center with c/o SOB.  Pt diagnosed with Covid19 and admitted.  Pt received 1 dose of Remdesivir then requested transfer.  CTA chest showed large pleural fluid and pulmonary infiltrates.  Pt requiring O2 at 3L NC sat 98%.  Afebrile.  Pt being treated with IV Steroids, IV ABX, Remdesivir.
Patient noted onset of vertigo just prior to her second dose of COVID-19 vaccine manufactured by Pfizer on May 13. Patient describes significant vertigo symptoms for 5 weeks after her second COVID-19 vaccine. Since that time symptoms have slowly improved but still persist. Patient notes nausea but denies vomiting. She is taking an old prescription for meclizine with some relief. My research indicates that approximately 11.8% of patients who receive the Pfizer COVID-19 vaccine experience dizziness. Patient is familiar with the Epley's maneuver but denies any relief in her symptoms by performing this maneuver. Very specific head movements seem to trigger her vertigo such as twisting turning or tilting her head to the left. Patient flies frequently due to her job. Patient states the symptoms are worse in the early morning and seem to improve through the day. She states that she is able to drive without difficulty. She denies any associated tinnitus. Weber and Renee tests were normal here today (7/23/21 Dr. report).
became sick both times; Initial information was received on 13-Oct-2020 regarding an unsolicited valid non-serious case from a consumer/non-heath care professional via social media.  This case a patient (demographics unknown) who became sick both times (malaise) after receiving INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination. The patient had received 2 flu shots.  On an unknown date, the patient became sick both times (malaise) (unknown latency, non-serious event) following the administration of INFLUENZA VACCINE. The reporter reported that flu shots are not copacetic with immune system. The efficacy of the shots was usually less than 40 percent.  No laboratory data was provided.   It was not reported if the patient received a corrective treatment.  At the time of report, the outcome of event was unknown.  There will be no information available on the batch number for this case.
Itching on the injection arm but it is more than first dose; Swelling on the injection arm but it is more than with the first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching on the injection arm but it is more than first dose) and VACCINATION SITE SWELLING (Swelling on the injection arm but it is more than with the first dose) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itching on the injection arm but it is more than first dose) and VACCINATION SITE SWELLING (Swelling on the injection arm but it is more than with the first dose). At the time of the report, VACCINATION SITE PRURITUS (Itching on the injection arm but it is more than first dose) and VACCINATION SITE SWELLING (Swelling on the injection arm but it is more than with the first dose) had not resolved.            No Concomitant medication details were provided.   No Treatment medication details were provided.   This case was linked to MOD-2021-315645 (Patient Link).
After 20 minutes, the tongue started to swell and lips. An hour later I had some hives on my stomach. This continued for a couple of days. 5 days later my face, eyes, lips and tongue are swollen. Difficulty breathing at times.
No adverse event; He entered the lot number and it says this vaccine is expired; This spontaneous case was reported by a patient and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (He entered the lot number and it says this vaccine is expired) and NO ADVERSE EVENT (No adverse event) in a 63-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Sep-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 21-Sep-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (He entered the lot number and it says this vaccine is expired). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (He entered the lot number and it says this vaccine is expired) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            No concomitant information provided  It was reported that The patient states he just got a booster vaccine on 21Sep2022 about 20 minutes ago. patient entered the lot number and it said the vaccine was expired. He was trying to check if he got the bivalent. The lot was 005M21A.Then the patient realized he might have given the lot number from a previous dose that he received back in April. He was unsure of the lot number of the dose that he received on 21Sep2022 because he could not read the writing on his card.  On 28Mar2021 patient received first dose of Moderna vaccine with lot number 008B21-2A On 26Arp2021 patient received second dose of Moderna vaccine with lot number 014C21A On 18Nov2021 patient received 1st booster dose of Moderna vaccine of 0.25 ml with lot number 027H21B  On 14Apr2022 patient received 2nd booster dose of Moderna vaccine of 0.25 ml with lot number 005M21A   No treatment information provided
Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 2/03/21, 3/03/2021 and 11/27/2021. Covid19 + 2/07/22. Presented to ED 2/11/22 c/o generalized weakness fever, back pain and leg pain both legs worse on the R leg with swelling and redness on the R leg as well, denies any trauma to the legs, she had a fever at home. Admitted Covid infx, R leg pain and abnormaol troponin.. CXR w/some left basal opacity. In the ER BP 151/84 with pulse of 111, the last pulse rate prior to the event was 94. INR was 1.2. Due to increasing swelling on the leg stat CT requested w/DIC labs. At the same time started having AMS, taken for stat brain CT. On arrival back to floor  patient was unresponsive and code blue was initiated, Treated with rocephin and steroids. Pt expired 02/11/22.
tingling/numbess up jaw below his nipple, starting in his chest. Small localized to around the artery, below my jaw line, creeping cheek, ear towards top of my head; tingling/numbess up jaw below his nipple, starting in his chest. Small localized to around the artery, below my jaw line, creeping cheek, ear towards top of my head; States hot; pain; uncomfortable; damage to nerves; It is hard to differentiate that sensation; This is a spontaneous report from a contactable consumer or other non healthcare professional. A adult male patient in his 60's received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 03May2021 (Batch/Lot Number: EW0170; Expiration Date: Aug2021) as dose 2, single for covid-19 immunisation. Medical history included, sinus congestion from an unknown date and unknown if ongoing rarely takes Sudafed for sinus congestion. The patient's concomitant medications were not reported. The patient previously took bnt162b2 for covid-19 immunisation and experienced adverse event, sudafed 12 hour for sinus congestion. The patient experienced tingling or numbness up the jaw below his nipple, starting in his chest. small localized to around the artery, below the jaw line, creeping cheek, ear towards top of the head states hot feeling, pain, uncomfortable feeling and damage to nerves on 2021 with outcome of not recovered.  No follow-up attempts are possible. No further information is expected.
pt exp fever, sz, crying, fever, dec appetite, febrile seizure, mizrocyticvarnmia hypochronic; fever, shaking tonic reaction, eyes seemed to roll back & resp seem to be depressed; pulse 212; URI; difficulty breathing, t104.5, slow;
cont deep aching, & swelling of lower arm & wrist since shot was given;tendons feel inflamed;
Starting within 20 minutes of injection, arm pain and swelling from injection site in top of shoulder began. Over the next 24 hours the pain and swelling increased down the left afrm to just below the elbow. The elbow joint felt stiff. Skin itched. I used a cool compress on the inflamed area of my arm. At about 1:00pm on 10/24/209 while working in my compute I got extremely dizzy. I had trouble getting out of the chair. It was difficuplt to get my legs to walk. I had to support myself on the wall and furniture to get the living room chair. On 10/24/2019 I saw P/A at Health clinic. recommended rest and cool compress and intake of fluids. The reaction cleared up as of 10/27/2019.
Muscle breakdown, muscle enzymes elevated along with liver enzymes, muscle pain with muscle spasms & sciatica to legs. Peripheral neuropathy along with Guillain Barr to vision. Was on prednisone 2 weeks, no improvement. Tizanidine for pain/muscle relaxer.
Swollen lymph node under right armpit (baseball size) and sore neck and ribs on right side.  Lymph node area sore as well.  Hard lump about 2in diameter on injection site.  Scratchy throat and night sweats.
fever; chills; muscle pain; extreme fatigue; felt like someone punched him and threw him down the street; This case was reported by a consumer and described the occurrence of fever in a 54-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pyrexia (1st dose received on 23rd September 2020 and also had fatigue, muscle pain and chills, refer case US2021013449).   On 16th December 2020, the patient received the 2nd dose of Shingrix. In January 2021, less than 2 months after receiving Shingrix, the patient experienced fever, chills, muscle pain, fatigue and feeling unwell. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the fever, chills, muscle pain, fatigue and feeling unwell were recovered/resolved.   It was unknown if the reporter considered the fever, chills, muscle pain, fatigue and feeling unwell to be related to Shingrix.  Additional details were provided as follows: The case was reported by patient himself. The patient experienced the same side effects fever, chills, muscle pain, fatigue with greater intensity. The patient had to put on an electric blanket with heat and he felt like someone punched him and threw him down the street. All the adverse events were recovered after 3 days. The reporter consented to follow up. This case was linked with case US2021013454, reported by the same reporter; Sender's Comments:  US-GLAXOSMITHKLINE-US2021013454:same reporter US-GLAXOSMITHKLINE-US2021013454:same reporter
The vial was reconstituted incorrectly. Rather than adding 1.8 ml of diluent, 0.8 ml of diluent was added.
Severe arm pain at the site a couple hours after injection. The pain is still severe a day later.  The next symptoms started on10/24/21 the day after the shot. Sharp shooting pains in abdomen and ovary area, they come and go.  Headache, shooting pain in right side of head and eye. Chills, muscle pain, muscle weakness, and fever of 100.4. These have been all day. When I got dose 2 I had most of these symptoms for two days after the shot. The shooting pains are new to this booster shot and my temperature is higher this shot.
Information has been received on 12-NOV-2018 regarding a case in litigation from a lawyer concerning a male patient of unknown age. There is no information regarding the patient's concurrent conditions, medical history or concomitant medications. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 2014, a pharmacist at a pharmacy administered the ZOSTAVAX (lot number, expiration, dose and route unknown) to the patient. On or about 2014, the patient was treated by a physician at a family practice center for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events is unknown. The causality of the events is related. Additional information has been requested.
Patient had Gardasil shot and then Depo-Provera about 1 week later. 2 months later, this past Friday she passed a mass of tissue vaginally that was approximately 5" X 2" and was in pain similar to labor. This child is not sexually active, has experience severe cramping. Concerned may have caused permanent damage to her uterus. Ultrasound today, gyn in the next few.
Patient broke out in hives and "got puffy in her face" - 1 1/2 hrs after receiving the nasal flu vaccine.
Headache, nausea, fatigue, malaise, two days later woke up at 4am with severe abdominal pain, caused pancreatitis flare and then diagnosed with thrombosis of hepatic and portal vein. Hospitalized for 11 days post diagnosis of pancreatitis and other complications after vaccination.
Headache. Myalgia, Arthralgia, fatigue, stiff neck Narrative:
some aches and pains; Initial information was received on 14-Nov-2023 regarding an unsolicited valid, courtesy case non-serious case received from a consumer/non-hcp.  This case involves a 80 years old female patient (76.4 kg) who experienced some aches and pains while receiving vaccines COVID-19 VACCINE and INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Pulmonary arterial hypertension.    On an unknown date, the patient received a  dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (dose, formulation, strength, lot and expiry date: unknown) via unknown route in unknown administration site for prophylactic vaccination (immunization).  On an unknown date, the patient received a  dose of suspect COVID-19 VACCINE not produced by Sanofi Pasteur (dose, formulation, strength, lot and expiry date: unknown) via unknown route in unknown administration site for Covid-19 immunization.  On an unknown date the patient developed a non-serious some aches and pains (pain) (unknown latency)   Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (some aches and pains).  At time of reporting, the outcome was Unknown for the event some aches and pains.